PATENTS OFFICE JOURNAL - Irish Patents Office

(No. 1985) Patents Office Journal (14/01/2004) 2640
Supplementary Protection Certificates Granted
The name and address of the grantee follows the number allocated to the application for grant of a certificate;
this number applies also to the granted certificate. The date in brackets following the name and address is the
date of grant of the certificate. The number of the basic Patent and the title of the invention are followed by
the name of the product for which the certificate is granted. Market authorisation references in respect of the
product concerned are also shown, followed by the date of expiry of the certificate.
1999003 ORION-CORPORATION ORIONINTIE Saunatontuntie 1, 02200 Espoo,
Finland
05/12/2003
Patent No: 60320; New pharmacologically active compounds, methods for the
preparation thereof, and compositions containing the same
Product: Entacapone, (E)-2-cyano-N,N-diethyl-3-(3,4-dihydroxy-5-ni trophenyl
(acrylamide) optionally in the form of a pharmaceutically acceptable salt thereof
Market Authorisation: Ireland EU/1/98/082/001 - 4, 16/09/1998
European Union EU/1/98/082/001 - 4, 16/09/1998
Certificate Expires on: 29/11/2012
2000012 NOVARTIS AG, Schwarzwaldalle 215, 4058 Basel, Switzgerald.
05/12/2003
Patent No: 80848; Aromatic compounds
Product: Trifloxystrobin
Market Authorisation: Ireland AP1399, 24/03/2000
Switzerland W 5759, 26/11/1998
Certificate Expires on: 25/11/2013
2000021 SYNTEX (U.S.A.) LLC, 3401 Hillview Avenue, Palo Alto, CA 94304, United
States of America
15/12/2003
Patent No: 63707; Nonapeptide and decapeptide analogs of LHRH useful as
LHRH antagonists
Product: Ganirelix or pharmaceutically acceptable salts thereof
Market Authorisation: Ireland EU/1/00/130/001 and EU/1/00/130/002,
17/05/2000
European Union EU/1/00/130/001 and EU/1/00/130/002, 17/05/2000
Certificate Expires on: 03/02/2013
2000026 NOVO NORDISK A/S, Novo Allé, DK-2880 Bagsvaerd, Denmark
15/12/2003
Patent No: 0705275; ASP-B28 INSULIN CRYSTALS
Product: Soluble insulin aspart/protamine-crystallised insulin aspart.
Market Authorisation: Ireland EU/1/00/142/001-002-003-004-005-006-007-008,
01/08/2000
Switzerland 55414 01, 55415 02, and 55416 02, 23/06/2000
Certificate Expires on: 22/06/2015